Kodiak Sciences Inc.(KOD)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

KOD Kodiak Sciences Inc.

交易中 05-29 10:39:00 EDT

36.49

+0.37

+1.02%

最高37.07	最低36.27	成交量4.95万
今开36.64	昨收36.12	日振幅2.21%
总市值22.83亿	流通市值13.46亿	总股本6,258万
成交额181.73万	换手率0.13%	流通股本3,688万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"KOD","market":"US","secType":"STK","nameCN":"Kodiak Sciences Inc.","latestPrice":36.49,"timestamp":1780065526971,"preClose":36.12,"halted":0,"volume":49459,"delay":0,"changeRate":0.01024363233665572,"floatShares":36879500,"shares":62578441,"eps":-4.157111,"marketStatus":"交易中","change":0.37,"latestTime":"05-29 10:39:00 EDT","open":36.64,"high":37.065,"low":36.265,"amount":1817275.251835,"amplitude":0.022148,"askPrice":36.58,"askSize":30,"bidPrice":36.21,"bidSize":134,"shortable":3,"etf":0,"ttmEps":-4.157111,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1780084800000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1538625600000,"exchange":"NASDAQ","adjPreClose":36.12,"preHourTrading":{"tag":"盘前","latestPrice":36.69,"preClose":36.12,"latestTime":"09:29 EDT","volume":560,"amount":20426.82152,"timestamp":1780061399999,"change":0.57,"changeRate":0.015781,"amplitude":0.017442},"postHourTrading":{"tag":"盘后","latestPrice":36.12,"preClose":36.12,"latestTime":"17:13 EDT","volume":24489,"amount":884529.82,"timestamp":1780002800801,"change":0,"changeRate":0,"amplitude":0.003322},"volumeRatio":0.563462,"impliedVol":1.2562,"impliedVolPercentile":0.8367},"requestUrl":"/m/hq/s/KOD/wiki","defaultTab":"wiki","newsList":[{"id":"1160948414","title":"Kodiak Sciences公布近期业务亮点及2025年第四季度和全年财务业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=1160948414","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1160948414?lang=zh_cn&edition=full","pubTime":"2026-04-01 04:46","pubTimestamp":1774989971,"startTime":"0","endTime":"0","summary":"Kodiak Sciences Inc.（以下简称\"公司\"）近日披露了2025年第四季度及全年的财务报告，并同步更新了企业最新动态。此次公告涵盖了公司在研发进展、管线拓展及战略布局等方面的关键信息，为投资者呈现了全面的运营图谱。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK4139","KOD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126955846","title":"异动解读 | 获多家券商上调目标价，Kodiak Sciences盘中大涨6.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=1126955846","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1126955846?lang=zh_cn&edition=full","pubTime":"2026-03-27 21:33","pubTimestamp":1774618405,"startTime":"0","endTime":"0","summary":"生物技术公司Kodiak Sciences Inc.今日盘中股价大幅上涨6.06%，引起了市场广泛关注。消息面上，此次股价上涨主要受到华尔街分析师积极行动的影响。根据相关报道，杰富瑞 将Kodiak Sciences的目标股价从39美元大幅上调至56美元。分析师上调目标价通常被视为对公司未来前景的乐观信号，这直接提振了市场信心。这些评级调整发生在常规分析师研究更新中，反映出机构对Kodiak Sciences在其专业领域内发展潜力的重新评估。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["KOD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130184401","title":"异动解读 | 获多家券商上调目标价，Kodiak Sciences盘前大涨5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=1130184401","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1130184401?lang=zh_cn&edition=full","pubTime":"2026-03-27 21:31","pubTimestamp":1774618271,"startTime":"0","endTime":"0","summary":"生物技术公司Kodiak Sciences Inc.  今日盘前股价大幅上涨5.56%，引起了市场关注。其中，杰富瑞将Kodiak Sciences的目标股价从39美元大幅上调至56美元。分析师上调目标价通常被视为对公司未来前景的乐观信号，这直接提振了市场信心，推动了股价在盘前交易时段走强。这些评级调整发生在周五的常规分析师研究更新中，反映出机构对Kodiak Sciences在其专业领域内发展潜力的重新评估。此类积极的分析师行动往往是短期内影响股价波动的重要因素。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["KOD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193829020","title":"Kodiak Sciences Inc.：Zenkuda在关键次要终点亦展现卓越疗效，风险降幅高达85%","url":"https://stock-news.laohu8.com/highlight/detail?id=1193829020","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1193829020?lang=zh_cn&edition=full","pubTime":"2026-03-26 18:05","pubTimestamp":1774519525,"startTime":"0","endTime":"0","summary":"Kodiak Sciences Inc.宣布，其研发药物Zenkuda在关键次要终点指标上同样表现出显著优势，相较安慰剂组实现85%的风险降低。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","KOD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134318557","title":"Kodiak Sciences公布GLOW2研究积极顶线结果：Zenkuda™在糖尿病视网膜病变三期试验中显著优于安慰剂","url":"https://stock-news.laohu8.com/highlight/detail?id=1134318557","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1134318557?lang=zh_cn&edition=full","pubTime":"2026-03-26 18:04","pubTimestamp":1774519489,"startTime":"0","endTime":"0","summary":"Kodiak Sciences Inc. (KOD) 宣布其GLOW2研究取得积极顶线结果，这是针对糖尿病视网膜病变的第二项三期临床试验。数据显示，实验性药物Zenkuda™（Tarcocimab Tedromer）在疗效上显著优于安慰剂对照组。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KOD","BK4505","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123063641","title":"Kodiak Sciences：Zenkuda研究显示良好安全性，耐受性佳，眼内炎症率为0%，白内障不良事件率仅2.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=1123063641","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1123063641?lang=zh_cn&edition=full","pubTime":"2026-03-26 18:03","pubTimestamp":1774519432,"startTime":"0","endTime":"0","summary":"Kodiak Sciences Inc. 公布的研究数据显示，其候选药物Zenkuda在临床试验中展现出优异的安全性和耐受性。该研究结果显示，患者眼内炎症发生率为零，而白内障相关不良事件的发生率仅为2.3%。这一积极数据为Zenkuda的后续开发提供了有力的安全性支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK4139","KOD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149024501","title":"Kodiak Sciences Inc.：Zenkuda展现强劲疗效，独立于GLP-1受体激动剂联合使用","url":"https://stock-news.laohu8.com/highlight/detail?id=1149024501","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1149024501?lang=zh_cn&edition=full","pubTime":"2026-03-26 18:03","pubTimestamp":1774519421,"startTime":"0","endTime":"0","summary":"Kodiak Sciences Inc.旗下药物Zenkuda在临床研究中表现出卓越疗效，其治疗效果不受是否联合使用GLP-1受体激动剂的影响。这一发现为糖尿病视网膜病变等疾病的治疗提供了新的临床依据，凸显了该药物独特的治疗机制和广泛适用性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","KOD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609550220","title":"Kodiak Sciences Inc盘中异动 大幅跳水5.05%报21.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2609550220","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609550220?lang=zh_cn&edition=full","pubTime":"2026-02-06 02:11","pubTimestamp":1770315075,"startTime":"0","endTime":"0","summary":"北京时间2026年02月06日02时11分，Kodiak Sciences Inc股票出现异动，股价快速下挫5.05%。截至发稿，该股报21.25美元/股，成交量23.9318万股，换手率0.39%，振幅6.08%。Kodiak Sciences Inc股票所在的生物技术行业中，整体跌幅为0.78%。Kodiak Sciences Inc公司简介：Kodiak Sciences Inc 是一家生物制药公司，专门开发治疗高患病率视网膜疾病的新型疗法。该公司的管道产品包括 Tarcocimab tedromer、KSI-501 和 KSI-101。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260206021115a6d82561&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260206021115a6d82561&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","KOD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603025915","title":"Kodiak Sciences Inc盘中异动 早盘股价大跌5.18%报26.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2603025915","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603025915?lang=zh_cn&edition=full","pubTime":"2026-01-12 22:48","pubTimestamp":1768229322,"startTime":"0","endTime":"0","summary":"北京时间2026年01月12日22时48分，Kodiak Sciences Inc股票出现异动，股价急速跳水5.18%。截至发稿，该股报26.29美元/股，成交量3.5119万股，换手率0.06%，振幅4.77%。Kodiak Sciences Inc股票所在的生物技术行业中，整体跌幅为0.89%。Kodiak Sciences Inc公司简介：Kodiak Sciences Inc 是一家生物制药公司，专门开发治疗高患病率视网膜疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011222484297a17748&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011222484297a17748&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","KOD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2588690048","title":"Kodiak Sciences Inc盘中异动 早盘大幅上涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588690048","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588690048?lang=zh_cn&edition=full","pubTime":"2025-12-02 23:09","pubTimestamp":1764688191,"startTime":"0","endTime":"0","summary":"北京时间2025年12月02日23时09分，Kodiak Sciences Inc股票出现异动，股价快速上涨5.06%。Kodiak Sciences Inc股票所在的生物技术行业中，整体涨幅为0.60%。其相关个股中，Polyrizon Ltd.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Ethzilla Corporation涨幅较大，Polyrizon Ltd.、Clearmind Medicine Inc.、Jasper Therapeutics, Inc.较为活跃，换手率分别为6706.29%、304.87%、170.07%，振幅较大的相关个股有Polyrizon Ltd.、Jasper Therapeutics, Inc.、Kazia Therapeutics Limited，振幅分别为67.41%、33.72%、29.95%。Kodiak Sciences Inc公司简介：Kodiak Sciences Inc 是一家生物制药公司，专门开发治疗高患病率视网膜疾病的新型疗法。该公司的管道产品包括 Tarcocimab tedromer、KSI-501 和 KSI-101。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251202230951978c02ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251202230951978c02ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","KOD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518222565","title":"Kodiak Sciences Inc盘中异动 股价大跌5.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518222565","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518222565?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:38","pubTimestamp":1741613884,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时38分，Kodiak Sciences Inc股票出现波动，股价急速跳水5.52%。Kodiak Sciences Inc股票所在的生物技术行业中，整体涨幅为0.41%。其相关个股中，Trevi Therapeutics, Inc.、Checkpoint Therapeutics, Inc.、Scisparc Ltd.涨幅较大，Scisparc Ltd.、Dogwood Therapeutics, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为471.88%、72.73%、52.37%，振幅较大的相关个股有Seer, Inc.、Scisparc Ltd.、Trevi Therapeutics, Inc.，振幅分别为98.72%、34.57%、25.35%。Kodiak Sciences Inc公司简介：Kodiak Sciences Inc 是一家生物制药公司，专门从事治疗高发性视网膜疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031021380498a29e60&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031021380498a29e60&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KOD","BK4505","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517166732","title":"Kodiak Sciences Inc盘中异动 股价大跌5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517166732","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517166732?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:36","pubTimestamp":1741271765,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时36分，Kodiak Sciences Inc股票出现异动，股价大幅下挫5.15%。Kodiak Sciences Inc股票所在的生物技术行业中，整体跌幅为0.52%。其相关个股中，Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 涨幅较大，Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为1027.16%、163.48%、52.81%，振幅较大的相关个股有Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 ，振幅分别为24.20%、23.83%、23.12%。Kodiak Sciences Inc公司简介：Kodiak Sciences Inc 是一家生物制药公司，专门从事治疗高发性视网膜疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223605989eb541&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223605989eb541&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","KOD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517948874","title":"Kodiak Sciences Inc盘中异动 大幅拉升5.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517948874","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517948874?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:31","pubTimestamp":1741185063,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时31分，Kodiak Sciences Inc股票出现波动，股价大幅上涨5.82%。Kodiak Sciences Inc股票所在的生物技术行业中，整体涨幅为0.08%。其相关个股中，Klotho Neurosciences Inc C/Wts 21/06/2029 、Chimerix, Inc.、Silexion Therapeutics Corp涨幅较大，Silexion Therapeutics Corp、Tc Biopharm  Plc、Zyversa Therapeutics, Inc.较为活跃，换手率分别为311.23%、251.30%、184.03%，振幅较大的相关个股有Aditxt, Inc.、4D Molecular Therapeutics, Inc.、Creative Medical Technology Holdings, Inc.，振幅分别为10.04%、8.56%、8.18%。Kodiak Sciences Inc公司简介：Kodiak Sciences Inc 是一家生物制药公司，专门从事治疗高发性视网膜疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223103abe9b064&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223103abe9b064&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KOD","BK4505","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516608059","title":"Kodiak Sciences Inc盘中异动 大幅下挫5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516608059","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516608059?lang=zh_cn&edition=full","pubTime":"2025-03-04 23:20","pubTimestamp":1741101607,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日23时20分，Kodiak Sciences Inc股票出现波动，股价快速跳水5.13%。Kodiak Sciences Inc股票所在的生物技术行业中，整体涨幅为0.42%。其相关个股中，Protagenic Therapeutics Inc C/Wts 29/04/2026 、Cyclacel Pharmaceuticals Inc 6% Cnv Pfd Usd、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Aeon Biopharma, Inc.、Windtree Therapeutics, Inc.、Protagenic Therapeutics, Inc.较为活跃，换手率分别为1171.96%、1133.58%、682.84%，振幅较大的相关个股有Cyclacel Pharmaceuticals Inc 6% Cnv Pfd Usd、Celularity Inc C/Wts 16/07/2026 、Protagenic Therapeutics Inc C/Wts 29/04/2026 ，振幅分别为66.03%、66.02%、64.44%。Kodiak Sciences Inc公司简介：Kodiak Sciences Inc 是一家生物制药公司，专门从事治疗高发性视网膜疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304232007989bb9d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304232007989bb9d1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KOD","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516300652","title":"Kodiak Sciences Inc盘中异动 快速跳水5.11%报3.90美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516300652","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516300652?lang=zh_cn&edition=full","pubTime":"2025-03-04 02:27","pubTimestamp":1741026436,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日02时27分，Kodiak Sciences Inc股票出现波动，股价快速下挫5.11%。截至发稿，该股报3.90美元/股，成交量9.8082万股，换手率0.19%，振幅9.61%。Kodiak Sciences Inc股票所在的生物技术行业中，整体涨幅为0.10%。Kodiak Sciences Inc公司简介：Kodiak Sciences Inc 是一家生物制药公司，专门从事治疗高发性视网膜疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304022717989a456a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304022717989a456a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","KOD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516374488","title":"Kodiak Sciences Inc盘中异动 临近午盘股价大涨5.24%报4.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516374488","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516374488?lang=zh_cn&edition=full","pubTime":"2025-03-01 00:45","pubTimestamp":1740761128,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日00时45分，Kodiak Sciences Inc股票出现异动，股价快速拉升5.24%。截至发稿，该股报4.22美元/股，成交量6.3753万股，换手率0.12%，振幅6.36%。Kodiak Sciences Inc股票所在的生物技术行业中，整体涨幅为0.31%。Kodiak Sciences Inc公司简介：Kodiak Sciences Inc 是一家生物制药公司，专门从事治疗高发性视网膜疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030100452896343872&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030100452896343872&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KOD","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514861629","title":"Kodiak Sciences Inc盘中异动 急速拉升5.21%报4.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514861629","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514861629?lang=zh_cn&edition=full","pubTime":"2025-02-27 03:20","pubTimestamp":1740597602,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日03时20分，Kodiak Sciences Inc股票出现波动，股价大幅上涨5.21%。截至发稿，该股报4.04美元/股，成交量32.7705万股，换手率0.62%，振幅7.03%。Kodiak Sciences Inc股票所在的生物技术行业中，整体跌幅为0.60%。Kodiak Sciences Inc公司简介：Kodiak Sciences Inc 是一家生物制药公司，专门从事治疗高发性视网膜疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270320029893deb7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270320029893deb7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","KOD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514015318","title":"Kodiak Sciences Inc盘中异动 股价大跌5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514015318","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514015318?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:12","pubTimestamp":1740496323,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时12分，Kodiak Sciences Inc股票出现波动，股价急速下挫5.20%。Kodiak Sciences Inc股票所在的生物技术行业中，整体涨幅为0.79%。其相关个股中，Silexion Therapeutics Corp、Abpro Holdings Inc C/Wts 12/11/2029 、Tc Biopharm  Plc C/Wts 10/02/2028 涨幅较大，Gt Biopharma, Inc.、Moleculin Biotech, Inc.、Adial Pharmaceuticals, Inc较为活跃，换手率分别为1040.92%、583.07%、532.48%，振幅较大的相关个股有Adial Pharmaceuticals, Inc、Gri Bio, Inc.、Silexion Therapeutics Corp，振幅分别为58.82%、56.51%、43.83%。Kodiak Sciences Inc公司简介：Kodiak Sciences Inc 是一家生物制药公司，专门从事治疗高发性视网膜疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022523120398925613&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022523120398925613&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","KOD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513205087","title":"Kodiak Sciences Inc盘中异动 早盘急速下跌5.17%报4.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513205087","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513205087?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:06","pubTimestamp":1740409561,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时06分，Kodiak Sciences Inc股票出现波动，股价急速下跌5.17%。截至发稿，该股报4.22美元/股，成交量1.8913万股，换手率0.04%，振幅5.89%。Kodiak Sciences Inc股票所在的生物技术行业中，整体涨幅为0.45%。Kodiak Sciences Inc公司简介：Kodiak Sciences Inc 是一家生物制药公司，专门从事治疗高发性视网膜疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230601962ea188&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230601962ea188&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","KOD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513216406","title":"Kodiak Sciences Inc盘中异动 下午盘快速下挫5.06%报4.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513216406","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513216406?lang=zh_cn&edition=full","pubTime":"2025-02-22 02:38","pubTimestamp":1740163138,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日02时38分，Kodiak Sciences Inc股票出现异动，股价快速下跌5.06%。截至发稿，该股报4.50美元/股，成交量10.2494万股，换手率0.19%，振幅6.54%。Kodiak Sciences Inc股票所在的生物技术行业中，整体涨幅为0.43%。Kodiak Sciences Inc公司简介：Kodiak Sciences Inc 是一家生物制药公司，专门从事治疗高发性视网膜疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222023858962bb23a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222023858962bb23a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","KOD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.kodiak.com;ir.kodiak.com","stockEarnings":[{"period":"1week","weight":-0.0345},{"period":"1month","weight":-0.2049},{"period":"3month","weight":0.3478},{"period":"6month","weight":0.5718},{"period":"1year","weight":9.32},{"period":"ytd","weight":0.2918}],"compareEarnings":[{"period":"1week","weight":0.016},{"period":"1month","weight":0.0603},{"period":"3month","weight":0.1},{"period":"6month","weight":0.1042},{"period":"1year","weight":0.2839},{"period":"ytd","weight":0.1066}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Kodiak Sciences Inc.于2009年6月22日以Oligasis LLC的名义成立为有限责任公司。2015年9月8日更名并在特拉华州注册成立公司。该公司是一家临床阶段的生物制药公司，专门研究治疗慢性高流行性视网膜疾病的新疗法。Kodiak Sciences Inc.最先进的候选产品是KSI-301，这是一种使用公司抗体生物聚合物偶联平台（ABC Platform）构建的生物疗法，旨在维持眼组织中有效且有效的药物水平。","yearOnYearQuotes":[{"month":1,"riseRate":0.375,"avgChangeRate":-0.076525},{"month":2,"riseRate":0.5,"avgChangeRate":-0.093763},{"month":3,"riseRate":0.125,"avgChangeRate":-0.076889},{"month":4,"riseRate":0.625,"avgChangeRate":0.017136},{"month":5,"riseRate":0.5,"avgChangeRate":0.04571},{"month":6,"riseRate":0.714286,"avgChangeRate":0.026986},{"month":7,"riseRate":0.571429,"avgChangeRate":0.078061},{"month":8,"riseRate":0.571429,"avgChangeRate":0.018756},{"month":9,"riseRate":0.714286,"avgChangeRate":0.127765},{"month":10,"riseRate":0.714286,"avgChangeRate":0.212883},{"month":11,"riseRate":0.75,"avgChangeRate":0.296496},{"month":12,"riseRate":0.625,"avgChangeRate":0.266402}],"exchange":"NASDAQ","name":"Kodiak Sciences Inc.","nameEN":"Kodiak Sciences Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Kodiak Sciences Inc.(KOD)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Kodiak Sciences Inc.(KOD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Kodiak Sciences Inc.,KOD,Kodiak Sciences Inc.股票,Kodiak Sciences Inc.股票老虎,Kodiak Sciences Inc.股票老虎国际,Kodiak Sciences Inc.行情,Kodiak Sciences Inc.股票行情,Kodiak Sciences Inc.股价,Kodiak Sciences Inc.股市,Kodiak Sciences Inc.股票价格,Kodiak Sciences Inc.股票交易,Kodiak Sciences Inc.股票购买,Kodiak Sciences Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Kodiak Sciences Inc.(KOD)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Kodiak Sciences Inc.(KOD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}